2020
DOI: 10.21203/rs.3.rs-57301/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A Preliminary Study on Blood Lipid Profile in Patients with COVID-19

Abstract: Background: Recently, dyslipidemia was observed in the patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate the blood lipid profile in the patients with COVID-19, and explore their predictive value for COVID-19 severity.Methods: 142 consecutive patients with COVID-19 admitted to HwaMei Hospital, University of Chinese Academy of Sciences, from January 23 to April 20, 2020, and 77 age- and gender-matched healthy subjects were included in this retrospective study. The blood lipid pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 22 publications
0
0
2
Order By: Relevance
“…It is possible that due to passing the early course of the disease, in this study there was no decrease in HDL-C level in the severe form of the disease. About dyslipidemia in Covid-19 patients, some studies have reported a decrease in lipid pro les as the disease progresses [23,24]. Contrary to our study, in studies by Li et al and Wang et al, a decrease in HDL-C levels was observed in severe cases of the disease, and this factor was reported as a risk factor for disease severity [23,25].…”
Section: Discussioncontrasting
confidence: 99%
“…It is possible that due to passing the early course of the disease, in this study there was no decrease in HDL-C level in the severe form of the disease. About dyslipidemia in Covid-19 patients, some studies have reported a decrease in lipid pro les as the disease progresses [23,24]. Contrary to our study, in studies by Li et al and Wang et al, a decrease in HDL-C levels was observed in severe cases of the disease, and this factor was reported as a risk factor for disease severity [23,25].…”
Section: Discussioncontrasting
confidence: 99%
“…It is possible that due to passing the early course of the disease, in this study there was no decrease in HDL-C level in the severe form of the disease. About dyslipidemia in Covid-19 patients, some studies have reported a decrease in lipid pro les as the disease progresses [23,24]. Contrary to our study, in studies by Li et al and Wang et al, a decrease in HDL-C levels was observed in severe cases of the disease, and this factor was reported as a risk factor for disease severity [23,25].…”
Section: Discussioncontrasting
confidence: 99%